Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)

Phase: N/A Priority: Normal
NCT ID: NCT02432846 Org: User:
Start: 04/30/15 End: 01/31/21 Due: 01/31/22

A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02686944 Org: User:
Start: 06/01/16 End: 05/10/19 Due: 05/10/20

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01974661 Org: User:
Start: 10/31/13 End: 06/28/17 Due: 06/28/18

Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT03697707 Org: User:
Start: 10/15/18 End: 12/31/25 Due: 12/31/26

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01525017 Org: User:
Start: 02/29/12 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03735290 Org: User:
Start: 01/14/19 End: 12/03/21 Due: 12/03/22

Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01373515 Org: User:
Start: 04/30/11 End: 05/31/13 Due: 05/31/14